These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21104588)

  • 1. Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes.
    Bala M; Kopp A; Wurm S; Büchler C; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):370-6. PubMed ID: 21104588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus.
    Kopp A; Bala M; Weigert J; Büchler C; Neumeier M; Aslanidis C; Schölmerich J; Schäffler A
    Cytokine; 2010 Jan; 49(1):51-7. PubMed ID: 19955001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acids as metabolic mediators in innate immunity.
    Kopp A; Gross P; Falk W; Bala M; Weigert J; Buechler C; Neumeier M; Schölmerich J; Schäffler A
    Eur J Clin Invest; 2009 Oct; 39(10):924-33. PubMed ID: 19563447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
    Neumeier M; Bauer S; Brühl H; Eisinger K; Kopp A; Abke S; Walter R; Schäffler A; Buechler C
    Cytokine; 2011 Dec; 56(3):573-80. PubMed ID: 21890375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes.
    Wehrwein G; Neumeier M; Schäffler A; Kopp A; Weigert J; Abke S; Schölmerich J; Buechler C
    Cardiovasc Diabetol; 2006 Mar; 5():5. PubMed ID: 16566827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women.
    Suarez EC; Lewis JG; Krishnan RR; Young KH
    Psychoneuroendocrinology; 2004 Oct; 29(9):1119-28. PubMed ID: 15219635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
    Hanifi-Moghaddam P; Kappler S; Seissler J; Müller-Scholze S; Martin S; Roep BO; Strassburger K; Kolb H; Schloot NC
    Diabet Med; 2006 Feb; 23(2):156-63. PubMed ID: 16433713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by LPS stimulated human monocytes isolated from HIV+ patients.
    Baqui AA; Jabra-Rizk MA; Kelley JI; Zhang M; Falkler WA; Meiller TF
    Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):401-21. PubMed ID: 10946822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.
    Schäffler A; Büchler C; Müller-Ladner U; Herfarth H; Ehling A; Paul G; Schölmerich J; Zietz B
    Horm Metab Res; 2004 Oct; 36(10):702-7. PubMed ID: 15523596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
    Al-Sari IE; Al-Quobaili FA; Kabalan YM
    Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular monocyte cytokine production and CD 14 expression are up-regulated in severe vs mild chronic heart failure.
    Conraads VM; Bosmans JM; Schuerwegh AJ; Goovaerts I; De Clerck LS; Stevens WJ; Bridts CH; Vrints CJ
    J Heart Lung Transplant; 2005 Jul; 24(7):854-9. PubMed ID: 15982613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of chemokines in acute myocardial infarction.
    Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
    Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis.
    Araya AV; Pavez V; Perez C; Gonzalez F; Columbo A; Aguirre A; Schiattino I; Aguillón JC
    Eur Cytokine Netw; 2003; 14(3):128-33. PubMed ID: 14656685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs).
    Møller AS; Ovstebø R; Haug KB; Joø GB; Westvik AB; Kierulf P
    Cytokine; 2005 Dec; 32(6):304-15. PubMed ID: 16406558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.